Urge Incontinence Clinical Trial
Official title:
Effects of External Neuromuscular Electrical Stimulation in Women With Urgency Urinary Incontinence: A Randomized Sham-Controlled Study
Verified date | February 2023 |
Source | Recep Tayyip Erdogan University Training and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To reveal the effects of Neuromuscular Electrical Stimulation (NMES) applied over the thigh on incontinence symptoms, pelvic floor muscle function, bladder function, quality of life and sexual function in women with urge urinary incontinence (UUI) symptoms. Our goal is to contribute to the literature on electrical stimulation (ES) applications used in UUI treatment. Female patients aged 18-65 years with UUI symptoms will be included in the study. Patients will be divided into 2 groups randomly. The first group will be given Neuromuscular Electrical Stimulation (NMES) and lifestyle suggestions (LSS) (NMES group). The second group will be given sham NMES in addition to LSS (SHAM ES group). Information about bladder irritants, voiding posture and behavior, weight control and pelvic floor muscle training will be provided in the LSS. ES applications will be performed 3 days a week for 30 minutes per session for 8 weeks. All participants will be evaluated pretreatment, after the 4th week and posttreatment. Pelvic floor muscle function will evulate with the Modified Oxford Scale. In addition, women's bladder function with the urinary diary for 3 days, incontinence symptoms with the International Incontinence Consultation Questionnaire-Short Form (ICIQ-SF) and the Coital Incontinence Score (CIS), quality of life with the King Health Questionnaire (KHQ) and Sexual Function will be evaluated with Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). At the end of the 8th week, both the Subjective perception of improvement and treatment satisfaction of the patients will be questioned
Status | Completed |
Enrollment | 34 |
Est. completion date | November 30, 2022 |
Est. primary completion date | June 30, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - who do not want to use medication, - who do not benefit from medication for a long time - who do not use any medication Exclusion Criteria: - Those with any malignant conditions, - those with neurological disease, - those with infection, - pregnancy, - those with pelvic organ prolapse above stage 2 according to the POP-Q staging, - those with cardiac implants and pacemakers, - those with cardiac arrhythmia, - those with urinary retention, - those with sensory loss, - copper coil intrauterine those who wear a vehicle, - patients with metal implants - patients with communication and cooperation problems |
Country | Name | City | State |
---|---|---|---|
Turkey | Recep Tayyip Erdogan University Guneysu Vocational School of Physical Therapy and Rehabilitation | Rize | Guneysu |
Lead Sponsor | Collaborator |
---|---|
Recep Tayyip Erdogan University Training and Research Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pelvic Floor Muscle Function | Pelvic Floor Muscle Function will be evulated with The Modified Oxford Scale (MOS).
It rates the Pelvic floor muscle contraction on a scale of 0-5; 0 = no contraction; 1 = minor muscle 'flicker'; 2 = weak muscle contraction; 3 = moderate muscle contraction; 4 = good muscle contraction and 5 = strong muscle contraction. |
8 weeks | |
Primary | Bladder Function | Bladder Function will be evulated with the bladder diary for 3 days | 8 weeks | |
Primary | Incontinence Symptoms | Incontinence symptoms will be evulated with The International Consultation of Incontinence Questionnaire - Short Form (ICIQ-SF) it has 5 questions and total score ranges is 1 - 5 (slight), 6 - 12 (moderate), 13 - 18 (severe) and 19 - 21 (very severe). | 8 weeks | |
Primary | Quality of Life Questionnaire | quality of life will be evulated with the King's Health Questionnaire (KHQ) It consists of 3 parts. In the first part; 2 questions evaluating General health perception, in the second part; 19 questions that divide the quality of life into different areas (Incontinence impact, role limitations, physical limitations, social limitations, personal relationships, emotions, sleep/ energy, general health status, symptom severity) and in the third part; It consists of 11 questions evaluating the severity of urinary symptoms.
The individual items in the domains are scaled from 0 (best) to 100 worst. Another dimension is added which is called as Symptom severity scale; where in there are 10 different bladder symptoms, the score ranges from 0 to 30 and the values are not converted to percentages. |
8 weeks | |
Primary | Sexual Function | Sexual Function will be evulated with the Pelvic Organ Prolapse Urinary Incontinence Sexual Questionnaire - 12 (Short Form) (PISQ-12-SF) The questionnaire is based on 12 items that allow investigation of three different domains of sexual life; behavior (items 1-4), physical (items 5-9) and partner-related (items 10-12). Scores are calculated by totaling the scores for each question with 0 = always to 4 = never. Reversed scoring is used for items 1, 2, 3 and 4. Higher PISQ-12-SF scores indicate a better sexual function. Maximum score is 48. | 8 weeks | |
Primary | End of Treatment Special Evaluations | Subjective perception of improvement and treatment satisfaction of the patients will be questioned | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03556891 -
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence
|
N/A | |
Active, not recruiting |
NCT04936464 -
Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
|
N/A | |
Completed |
NCT04470765 -
Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence
|
N/A | |
Recruiting |
NCT05415865 -
The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder
|
Phase 3 | |
Recruiting |
NCT05099419 -
Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence
|
Early Phase 1 | |
Recruiting |
NCT05874375 -
UCon Treatment of Overactive Bladder (OAB) in Males
|
N/A | |
Active, not recruiting |
NCT05241379 -
AURA-2: Augmenting Urinary Reflex Activity
|
N/A | |
Completed |
NCT02657057 -
Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB
|
N/A | |
Withdrawn |
NCT00773552 -
Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
|
Phase 4 | |
Recruiting |
NCT04752709 -
Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women
|
N/A | |
Recruiting |
NCT03755089 -
Oral vs Intravesical Analgesia for Office Bladder Botox Injections
|
Phase 4 | |
Terminated |
NCT03687164 -
Group Medical Visits for Latina Women With Urgency Urinary Incontinence
|
N/A | |
Withdrawn |
NCT03697954 -
Direct Full-stage Implantation of Sacral Neuromodulation
|
||
Completed |
NCT00337558 -
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)
|
Phase 4 | |
Completed |
NCT03180372 -
Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence
|
N/A | |
Completed |
NCT05783219 -
Lidocaine Patches Prior to Percutaneous Nerve Evaluation
|
Phase 2 | |
Active, not recruiting |
NCT05308979 -
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
|
Phase 4 | |
Completed |
NCT03672461 -
A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women
|
N/A | |
Completed |
NCT01391780 -
Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence
|
N/A | |
Completed |
NCT03655054 -
eCoin for OAB Feasibility Follow-on Study
|
N/A |